Zydus Lifesciences receives USFDA nod

Good morning!

Here are the top stories to start your day.

For more updates on F&O. Click here.

⭐ Zydus Lifesciences receives USFDA nod 

Pharma company has received approval from the USFDA to market generic drugs apixaban and olmesartan medoxomil & hydrochlorothiazide tablets. Both drugs had annual sales of $18,876 million and $41.7 million, respectively in the United States.   

⭐ India’s core sector output rises 

India’s core industrial output registered a 7.8% growth in January 2023, against a 4% growth during the same period last year. The core sector comprises eight key infrastructure industries, including coal, fertilisers and others. These industries have over 40% weightage in the index of industrial production (IIP).

⭐ SEBI gives go-ahead to three IPOs 

As many as three companies have received a go-ahead from market regulator SEBI to raise funds through IPO. Staffing firm FirstMeridian Business Services, gas distributor IRM Energy and textile machinery firm Lohia Corp have received go-ahead to float initial share-sale.

Global markets (at 9:30 AM today)

Fact of the day

As per a new industry report, 5G services could contribute $450 billion to India’s GDP by 2040

Source: Business Standard